2. Signaling Pathways
  3. GPCR/G Protein
  4. CRFR
  5. CRFR1 Isoform
  6. CRFR1 Inhibitor

CRFR1 Inhibitor

CRFR1 Inhibitor (1):

Cat. No. Product Name Effect Purity
  • HY-113603
    Tildacerfont
    		Inhibitor 98.60%
    Tildacerfont (SPR001; LY2371712) is an orally active, blood-brain barrier-penetrant selective corticotropin-releasing factor type 1 (CRF1) receptor antagonist. Tildacerfont selectively blocks CRF1 receptors, thereby inhibiting the release of pituitary adrenocorticotropic hormone (ACTH). Tildacerfont can be used in research related to congenital adrenal hyperplasia.